Reuters logo
BRIEF-Genmab Q1 oper profit DKK 46 million; above expectations
May 10, 2017 / 3:10 PM / 6 months ago

BRIEF-Genmab Q1 oper profit DKK 46 million; above expectations

May 10 (Reuters) - GENMAB

* Q1 USD 255 MILLION IN NET SALES OF DARZALEX® (DARATUMUMAB); RESULTING IN ROYALTY INCOME OF DKK 211 MILLION

* GENMAB - USD 255 MILLION IN NET SALES OF DARZALEX IN Q1

* Q1 REVENUE DKK 251 MILLION (REUTERS POLL DKK 263 MILLION)

* GENMAB - IS MAINTAINING ITS 2017 FINANCIAL GUIDANCE PUBLISHED ON FEBRUARY 22, 2017.

* Q1 OPERATING PROFIT DKK 46 MILLION (REUTERS POLL DKK 24.7 MILLION) Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below